https://daikikumakura.github.io/2026-10-28https://daikikumakura.github.io/profile.htmlhttps://daikikumakura.github.io/writing.html2026-10-28https://daikikumakura.github.io/software.htmlhttps://daikikumakura.github.io/publication.htmlhttps://daikikumakura.github.io/activity.htmlhttps://daikikumakura.github.io/writing-ja.html2026-10-28https://daikikumakura.github.io/writing/prism-potency-reliability.html2026-10-28https://daikikumakura.github.io/writing/shared/prism-potency-reliability/figures/fig1_observed_curves.pnghttps://daikikumakura.github.io/writing/shared/prism-potency-reliability/figures/fig2_ec50_profiles.pnghttps://daikikumakura.github.io/writing/shared/prism-potency-reliability/figures/fig3_conditional_sensitivity.pnghttps://daikikumakura.github.io/writing/prism-potency-reliability-en.html2026-10-28https://daikikumakura.github.io/writing/shared/prism-potency-reliability/figures/fig1_observed_curves.pnghttps://daikikumakura.github.io/writing/shared/prism-potency-reliability/figures/fig2_ec50_profiles.pnghttps://daikikumakura.github.io/writing/shared/prism-potency-reliability/figures/fig3_conditional_sensitivity.pnghttps://daikikumakura.github.io/writing/gemcitabine-infusion.html2026-10-28https://daikikumakura.github.io/writing/shared/gemcitabine-infusion/figures/01-timecourse.pnghttps://daikikumakura.github.io/writing/shared/gemcitabine-infusion/figures/02-formation-comparison.pnghttps://daikikumakura.github.io/writing/shared/gemcitabine-infusion/figures/03-boundary-and-tail.pnghttps://daikikumakura.github.io/writing/gemcitabine-infusion-en.html2026-10-28https://daikikumakura.github.io/writing/shared/gemcitabine-infusion/figures/01-timecourse.pnghttps://daikikumakura.github.io/writing/shared/gemcitabine-infusion/figures/02-formation-comparison.pnghttps://daikikumakura.github.io/writing/shared/gemcitabine-infusion/figures/03-boundary-and-tail.pnghttps://daikikumakura.github.io/writing/alphaprotein-novo.html2026-10-28https://daikikumakura.github.io/writing/shared/alphaprotein-novo/figures/01-denominators.pnghttps://daikikumakura.github.io/writing/alphaprotein-novo-en.html2026-10-28https://daikikumakura.github.io/writing/shared/alphaprotein-novo/figures/01-denominators.pnghttps://daikikumakura.github.io/writing/organ-lesion-response.html2026-10-28https://daikikumakura.github.io/writing/shared/organ-lesion-response/figures/aggregate-versus-lesion.pnghttps://daikikumakura.github.io/writing/shared/organ-lesion-response/figures/within-patient-organ.pnghttps://daikikumakura.github.io/writing/organ-lesion-response-en.html2026-10-28https://daikikumakura.github.io/writing/shared/organ-lesion-response/figures/aggregate-versus-lesion.pnghttps://daikikumakura.github.io/writing/shared/organ-lesion-response/figures/within-patient-organ.pnghttps://daikikumakura.github.io/writing/map-unprofiled-drugs.html2026-10-28https://daikikumakura.github.io/writing/shared/map-unprofiled-drugs/figures/01-drug-advantages.pnghttps://daikikumakura.github.io/writing/shared/map-unprofiled-drugs/figures/02-knowledge-stages.pnghttps://daikikumakura.github.io/writing/map-unprofiled-drugs-en.html2026-10-28https://daikikumakura.github.io/writing/shared/map-unprofiled-drugs/figures/01-drug-advantages.pnghttps://daikikumakura.github.io/writing/shared/map-unprofiled-drugs/figures/02-knowledge-stages.pnghttps://daikikumakura.github.io/writing/hidden-mediator-networks.html2026-10-28https://daikikumakura.github.io/writing/shared/hidden-mediator-networks/figures/three-structures.pnghttps://daikikumakura.github.io/writing/shared/hidden-mediator-networks/figures/mediator-fit-and-intervention.pnghttps://daikikumakura.github.io/writing/hidden-mediator-networks-en.html2026-10-28https://daikikumakura.github.io/writing/shared/hidden-mediator-networks/figures/three-structures.pnghttps://daikikumakura.github.io/writing/shared/hidden-mediator-networks/figures/mediator-fit-and-intervention.pnghttps://daikikumakura.github.io/writing/trop2-payload-exposure.html2026-10-28https://daikikumakura.github.io/writing/shared/trop2-payload-exposure/figures/label-version-differences.pnghttps://daikikumakura.github.io/writing/shared/trop2-payload-exposure/figures/dar-definition-sensitivity.pnghttps://daikikumakura.github.io/writing/trop2-payload-exposure-en.html2026-10-28https://daikikumakura.github.io/writing/shared/trop2-payload-exposure/figures/label-version-differences.pnghttps://daikikumakura.github.io/writing/shared/trop2-payload-exposure/figures/dar-definition-sensitivity.pnghttps://daikikumakura.github.io/writing/capivasertib-rest-schedule.html2026-10-28https://daikikumakura.github.io/writing/shared/capivasertib-rest-schedule/figures/01-schedules.pnghttps://daikikumakura.github.io/writing/shared/capivasertib-rest-schedule/figures/02-paired.pnghttps://daikikumakura.github.io/writing/shared/capivasertib-rest-schedule/figures/03-sensitivity.pnghttps://daikikumakura.github.io/writing/capivasertib-rest-schedule-en.html2026-10-28https://daikikumakura.github.io/writing/shared/capivasertib-rest-schedule/figures/01-schedules.pnghttps://daikikumakura.github.io/writing/shared/capivasertib-rest-schedule/figures/02-paired.pnghttps://daikikumakura.github.io/writing/shared/capivasertib-rest-schedule/figures/03-sensitivity.pnghttps://daikikumakura.github.io/writing/repotrectinib-escalation.html2026-10-28https://daikikumakura.github.io/writing/shared/repotrectinib-escalation/figures/01-timecourse.pnghttps://daikikumakura.github.io/writing/shared/repotrectinib-escalation/figures/02-paired.pnghttps://daikikumakura.github.io/writing/shared/repotrectinib-escalation/figures/03-sensitivity.pnghttps://daikikumakura.github.io/writing/repotrectinib-escalation-en.html2026-10-28https://daikikumakura.github.io/writing/shared/repotrectinib-escalation/figures/01-timecourse.pnghttps://daikikumakura.github.io/writing/shared/repotrectinib-escalation/figures/02-paired.pnghttps://daikikumakura.github.io/writing/shared/repotrectinib-escalation/figures/03-sensitivity.pnghttps://daikikumakura.github.io/writing/boltz2-assay-finetuning.html2026-10-28https://daikikumakura.github.io/writing/shared/boltz2-assay-finetuning/figures/01-label-budget.pnghttps://daikikumakura.github.io/writing/shared/boltz2-assay-finetuning/figures/02-rescoring-budget.pnghttps://daikikumakura.github.io/writing/boltz2-assay-finetuning-en.html2026-10-28https://daikikumakura.github.io/writing/shared/boltz2-assay-finetuning/figures/01-label-budget.pnghttps://daikikumakura.github.io/writing/shared/boltz2-assay-finetuning/figures/02-rescoring-budget.pnghttps://daikikumakura.github.io/writing/model-data-information.html2026-10-28https://daikikumakura.github.io/writing/shared/model-data-information/figures/time-information.pnghttps://daikikumakura.github.io/writing/shared/model-data-information/figures/metric-dilution.pnghttps://daikikumakura.github.io/writing/model-data-information-en.html2026-10-28https://daikikumakura.github.io/writing/shared/model-data-information/figures/time-information.pnghttps://daikikumakura.github.io/writing/shared/model-data-information/figures/metric-dilution.pnghttps://daikikumakura.github.io/writing/prediction-vs-mechanism.html2026-10-28https://daikikumakura.github.io/writing/shared/prediction-vs-mechanism/figures/identifiability.pnghttps://daikikumakura.github.io/writing/prediction-vs-mechanism-en.html2026-10-28https://daikikumakura.github.io/writing/shared/prediction-vs-mechanism/figures/identifiability.pnghttps://daikikumakura.github.io/writing/psa-early-observation.html2026-10-28https://daikikumakura.github.io/writing/shared/psa-early-observation/figures/target-availability.pnghttps://daikikumakura.github.io/writing/shared/psa-early-observation/figures/prediction-comparison.pnghttps://daikikumakura.github.io/writing/shared/psa-early-observation/figures/interval-calibration.pnghttps://daikikumakura.github.io/writing/shared/psa-early-observation/figures/regrowth-identification.pnghttps://daikikumakura.github.io/writing/shared/psa-early-observation/figures/prediction-sensitivity.pnghttps://daikikumakura.github.io/writing/psa-early-observation-ja.html2026-10-28https://daikikumakura.github.io/writing/shared/psa-early-observation/figures/target-availability.pnghttps://daikikumakura.github.io/writing/shared/psa-early-observation/figures/prediction-comparison.pnghttps://daikikumakura.github.io/writing/shared/psa-early-observation/figures/interval-calibration.pnghttps://daikikumakura.github.io/writing/shared/psa-early-observation/figures/regrowth-identification.pnghttps://daikikumakura.github.io/writing/shared/psa-early-observation/figures/prediction-sensitivity.pnghttps://daikikumakura.github.io/writing/b7h3-adc-dose-information.html2026-10-28https://daikikumakura.github.io/writing/shared/b7h3-adc-dose-information/figures/endpoint-evidence.pnghttps://daikikumakura.github.io/writing/shared/b7h3-adc-dose-information/figures/tradeoff-uncertainty.pnghttps://daikikumakura.github.io/writing/shared/b7h3-adc-dose-information/figures/information-value.pnghttps://daikikumakura.github.io/writing/shared/b7h3-adc-dose-information/figures/assumption-sensitivity.pnghttps://daikikumakura.github.io/writing/b7h3-adc-dose-information-ja.html2026-10-28https://daikikumakura.github.io/writing/shared/b7h3-adc-dose-information/figures/endpoint-evidence.pnghttps://daikikumakura.github.io/writing/shared/b7h3-adc-dose-information/figures/tradeoff-uncertainty.pnghttps://daikikumakura.github.io/writing/shared/b7h3-adc-dose-information/figures/information-value.pnghttps://daikikumakura.github.io/writing/shared/b7h3-adc-dose-information/figures/assumption-sensitivity.pnghttps://daikikumakura.github.io/writing/treatment-duration-benefit-risk.html2026-10-28https://daikikumakura.github.io/writing/shared/treatment-duration-benefit-risk/figures/benefit-risk-evidence.pnghttps://daikikumakura.github.io/writing/shared/treatment-duration-benefit-risk/figures/noninferiority-margin.pnghttps://daikikumakura.github.io/writing/shared/treatment-duration-benefit-risk/figures/missingness-bounds.pnghttps://daikikumakura.github.io/writing/treatment-duration-benefit-risk-ja.html2026-10-28https://daikikumakura.github.io/writing/shared/treatment-duration-benefit-risk/figures/benefit-risk-evidence.pnghttps://daikikumakura.github.io/writing/shared/treatment-duration-benefit-risk/figures/noninferiority-margin.pnghttps://daikikumakura.github.io/writing/shared/treatment-duration-benefit-risk/figures/missingness-bounds.pnghttps://daikikumakura.github.io/writing/fixed-vs-weight-dosing.html2026-10-28https://daikikumakura.github.io/writing/shared/fixed-vs-weight-dosing/figures/01-trough-by-weight.pnghttps://daikikumakura.github.io/writing/shared/fixed-vs-weight-dosing/figures/02-below-floor-by-weight.pnghttps://daikikumakura.github.io/writing/shared/fixed-vs-weight-dosing/figures/03-sensitivity-heavy.pnghttps://daikikumakura.github.io/writing/fixed-vs-weight-dosing-en.html2026-10-28https://daikikumakura.github.io/writing/shared/fixed-vs-weight-dosing/figures/01-trough-by-weight.pnghttps://daikikumakura.github.io/writing/shared/fixed-vs-weight-dosing/figures/02-below-floor-by-weight.pnghttps://daikikumakura.github.io/writing/shared/fixed-vs-weight-dosing/figures/03-sensitivity-heavy.pnghttps://daikikumakura.github.io/writing/ras-inhibitor-target-coverage.html2026-10-28https://daikikumakura.github.io/writing/shared/ras-inhibitor-target-coverage/figures/01-public-model.pnghttps://daikikumakura.github.io/writing/shared/ras-inhibitor-target-coverage/figures/02-mechanism.pnghttps://daikikumakura.github.io/writing/shared/ras-inhibitor-target-coverage/figures/03-phase.pnghttps://daikikumakura.github.io/writing/shared/ras-inhibitor-target-coverage/figures/04-pareto.pnghttps://daikikumakura.github.io/writing/shared/ras-inhibitor-target-coverage/figures/05-sensitivity.pnghttps://daikikumakura.github.io/writing/shared/ras-inhibitor-target-coverage/figures/06-interruptions.pnghttps://daikikumakura.github.io/writing/shared/ras-inhibitor-target-coverage/figures/07-absorption.pnghttps://daikikumakura.github.io/writing/shared/ras-inhibitor-target-coverage/figures/09-changing-clearance.pnghttps://daikikumakura.github.io/writing/shared/ras-inhibitor-target-coverage/figures/08-confounding.pnghttps://daikikumakura.github.io/writing/ras-inhibitor-target-coverage-ja.html2026-10-28https://daikikumakura.github.io/writing/shared/ras-inhibitor-target-coverage/figures/01-public-model.pnghttps://daikikumakura.github.io/writing/shared/ras-inhibitor-target-coverage/figures/02-mechanism.pnghttps://daikikumakura.github.io/writing/shared/ras-inhibitor-target-coverage/figures/03-phase.pnghttps://daikikumakura.github.io/writing/shared/ras-inhibitor-target-coverage/figures/04-pareto.pnghttps://daikikumakura.github.io/writing/shared/ras-inhibitor-target-coverage/figures/05-sensitivity.pnghttps://daikikumakura.github.io/writing/shared/ras-inhibitor-target-coverage/figures/06-interruptions.pnghttps://daikikumakura.github.io/writing/shared/ras-inhibitor-target-coverage/figures/07-absorption.pnghttps://daikikumakura.github.io/writing/shared/ras-inhibitor-target-coverage/figures/09-changing-clearance.pnghttps://daikikumakura.github.io/writing/shared/ras-inhibitor-target-coverage/figures/08-confounding.pnghttps://daikikumakura.github.io/writing/on-treatment-immune-change.html2026-10-28https://daikikumakura.github.io/writing/shared/on-treatment-immune-change/figures/paired-expression.pnghttps://daikikumakura.github.io/writing/shared/on-treatment-immune-change/figures/change-by-response.pnghttps://daikikumakura.github.io/writing/shared/on-treatment-immune-change/figures/association-validation.pnghttps://daikikumakura.github.io/writing/on-treatment-immune-change-ja.html2026-10-28https://daikikumakura.github.io/writing/shared/on-treatment-immune-change/figures/paired-expression.pnghttps://daikikumakura.github.io/writing/shared/on-treatment-immune-change/figures/change-by-response.pnghttps://daikikumakura.github.io/writing/shared/on-treatment-immune-change/figures/association-validation.pnghttps://daikikumakura.github.io/writing/borrowing-prior-dose-selection.html2026-10-28https://daikikumakura.github.io/writing/shared/borrowing-prior-dose-selection/figures/01-regret-change.pnghttps://daikikumakura.github.io/writing/shared/borrowing-prior-dose-selection/figures/02-correct-selection.pnghttps://daikikumakura.github.io/writing/borrowing-prior-dose-selection-en.html2026-10-28https://daikikumakura.github.io/writing/shared/borrowing-prior-dose-selection/figures/01-regret-change.pnghttps://daikikumakura.github.io/writing/shared/borrowing-prior-dose-selection/figures/02-correct-selection.pnghttps://daikikumakura.github.io/writing/tumor-dropout-sensitivity.html2026-10-28https://daikikumakura.github.io/writing/shared/tumor-dropout-sensitivity/figures/01-trajectories.pnghttps://daikikumakura.github.io/writing/shared/tumor-dropout-sensitivity/figures/02-delta-sensitivity.pnghttps://daikikumakura.github.io/writing/shared/tumor-dropout-sensitivity/figures/03-simulation.pnghttps://daikikumakura.github.io/writing/tumor-dropout-sensitivity-ja.html2026-10-28https://daikikumakura.github.io/writing/shared/tumor-dropout-sensitivity/figures/01-trajectories.pnghttps://daikikumakura.github.io/writing/shared/tumor-dropout-sensitivity/figures/02-delta-sensitivity.pnghttps://daikikumakura.github.io/writing/shared/tumor-dropout-sensitivity/figures/03-simulation.pnghttps://daikikumakura.github.io/writing/tcell-engager-decision-framework.html2026-10-28https://daikikumakura.github.io/writing/shared/tcell-engager-decision-framework/figures/01-workflow.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-decision-framework/figures/02-pk-validation.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-decision-framework/figures/03-efficacy.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-decision-framework/figures/04-crs-evidence.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-decision-framework/figures/05-crs-posterior.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-decision-framework/figures/11-prior-trace.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-decision-framework/figures/06-step-up.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-decision-framework/figures/07-maintenance.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-decision-framework/figures/08-feasibility.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-decision-framework/figures/09-information-value.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-decision-framework/figures/10-sampling.pnghttps://daikikumakura.github.io/writing/tcell-engager-decision-framework-ja.html2026-10-28https://daikikumakura.github.io/writing/shared/tcell-engager-decision-framework/figures/01-workflow.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-decision-framework/figures/02-pk-validation.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-decision-framework/figures/03-efficacy.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-decision-framework/figures/04-crs-evidence.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-decision-framework/figures/05-crs-posterior.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-decision-framework/figures/11-prior-trace.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-decision-framework/figures/06-step-up.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-decision-framework/figures/07-maintenance.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-decision-framework/figures/08-feasibility.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-decision-framework/figures/09-information-value.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-decision-framework/figures/10-sampling.pnghttps://daikikumakura.github.io/writing/sotorasib-dose-comparison.html2026-10-28https://daikikumakura.github.io/writing/shared/sotorasib-dose-comparison/figures/fig1_group_differences.pnghttps://daikikumakura.github.io/writing/shared/sotorasib-dose-comparison/figures/fig2_decision_by_weight.pnghttps://daikikumakura.github.io/writing/shared/sotorasib-dose-comparison/figures/fig3_sensitivity.pnghttps://daikikumakura.github.io/writing/sotorasib-dose-comparison-en.html2026-10-28https://daikikumakura.github.io/writing/shared/sotorasib-dose-comparison/figures/fig1_group_differences.pnghttps://daikikumakura.github.io/writing/shared/sotorasib-dose-comparison/figures/fig2_decision_by_weight.pnghttps://daikikumakura.github.io/writing/shared/sotorasib-dose-comparison/figures/fig3_sensitivity.pnghttps://daikikumakura.github.io/writing/immune-outcome-validation.html2026-10-27https://daikikumakura.github.io/writing/shared/immune-outcome-validation/figures/cohort-flow.pnghttps://daikikumakura.github.io/writing/shared/immune-outcome-validation/figures/model-equation.pnghttps://daikikumakura.github.io/writing/shared/immune-outcome-validation/figures/discrimination.pnghttps://daikikumakura.github.io/writing/shared/immune-outcome-validation/figures/calibration.pnghttps://daikikumakura.github.io/writing/shared/immune-outcome-validation/figures/score-shift.pnghttps://daikikumakura.github.io/writing/immune-outcome-validation-ja.html2026-10-27https://daikikumakura.github.io/writing/shared/immune-outcome-validation/figures/cohort-flow.pnghttps://daikikumakura.github.io/writing/shared/immune-outcome-validation/figures/model-equation.pnghttps://daikikumakura.github.io/writing/shared/immune-outcome-validation/figures/discrimination.pnghttps://daikikumakura.github.io/writing/shared/immune-outcome-validation/figures/calibration.pnghttps://daikikumakura.github.io/writing/shared/immune-outcome-validation/figures/score-shift.pnghttps://daikikumakura.github.io/writing/er-protac-pkpd.html2026-10-27https://daikikumakura.github.io/writing/shared/er-protac-pkpd/figures/01-public-concentrations.pnghttps://daikikumakura.github.io/writing/shared/er-protac-pkpd/figures/02-single-dose.pnghttps://daikikumakura.github.io/writing/shared/er-protac-pkpd/figures/03-schedules.pnghttps://daikikumakura.github.io/writing/shared/er-protac-pkpd/figures/04-metrics.pnghttps://daikikumakura.github.io/writing/er-protac-pkpd-en.html2026-10-27https://daikikumakura.github.io/writing/shared/er-protac-pkpd/figures/01-public-concentrations.pnghttps://daikikumakura.github.io/writing/shared/er-protac-pkpd/figures/02-single-dose.pnghttps://daikikumakura.github.io/writing/shared/er-protac-pkpd/figures/03-schedules.pnghttps://daikikumakura.github.io/writing/shared/er-protac-pkpd/figures/04-metrics.pnghttps://daikikumakura.github.io/writing/virtual-cell-target-evaluation.html2026-10-27https://daikikumakura.github.io/writing/shared/virtual-cell-target-evaluation/figures/toy-effects.pnghttps://daikikumakura.github.io/writing/shared/virtual-cell-target-evaluation/figures/toy-scores.pnghttps://daikikumakura.github.io/writing/virtual-cell-target-evaluation-en.html2026-10-27https://daikikumakura.github.io/writing/shared/virtual-cell-target-evaluation/figures/toy-effects.pnghttps://daikikumakura.github.io/writing/shared/virtual-cell-target-evaluation/figures/toy-scores.pnghttps://daikikumakura.github.io/writing/nimotuzumab-poppk.html2026-10-27https://daikikumakura.github.io/writing/shared/nimotuzumab-poppk/a03/figures/01-gof.pnghttps://daikikumakura.github.io/writing/shared/nimotuzumab-poppk/a03/figures/08-residual-occasion.pnghttps://daikikumakura.github.io/writing/shared/nimotuzumab-poppk/a03/figures/02-loso.pnghttps://daikikumakura.github.io/writing/shared/nimotuzumab-poppk/a03/figures/03-vpc.pnghttps://daikikumakura.github.io/writing/shared/nimotuzumab-poppk/a03/figures/06-bootstrap.pnghttps://daikikumakura.github.io/writing/shared/nimotuzumab-poppk/a03/figures/07-profile.pnghttps://daikikumakura.github.io/writing/shared/nimotuzumab-poppk/a03/figures/04-dose-exposure.pnghttps://daikikumakura.github.io/writing/shared/nimotuzumab-poppk/a03/figures/05-interval-exposure.pnghttps://daikikumakura.github.io/writing/nimotuzumab-poppk-en.html2026-10-27https://daikikumakura.github.io/writing/shared/nimotuzumab-poppk/a03/figures/01-gof.pnghttps://daikikumakura.github.io/writing/shared/nimotuzumab-poppk/a03/figures/08-residual-occasion.pnghttps://daikikumakura.github.io/writing/shared/nimotuzumab-poppk/a03/figures/02-loso.pnghttps://daikikumakura.github.io/writing/shared/nimotuzumab-poppk/a03/figures/03-vpc.pnghttps://daikikumakura.github.io/writing/shared/nimotuzumab-poppk/a03/figures/06-bootstrap.pnghttps://daikikumakura.github.io/writing/shared/nimotuzumab-poppk/a03/figures/07-profile.pnghttps://daikikumakura.github.io/writing/shared/nimotuzumab-poppk/a03/figures/04-dose-exposure.pnghttps://daikikumakura.github.io/writing/shared/nimotuzumab-poppk/a03/figures/05-interval-exposure.pnghttps://daikikumakura.github.io/writing/tumor-kinetics-landmark.html2026-10-27https://daikikumakura.github.io/writing/shared/tumor-kinetics-landmark/figures/fig1-availability.pnghttps://daikikumakura.github.io/writing/shared/tumor-kinetics-landmark/figures/fig2-survival-discrimination.pnghttps://daikikumakura.github.io/writing/shared/tumor-kinetics-landmark/figures/fig3-next-measurement.pnghttps://daikikumakura.github.io/writing/tumor-kinetics-landmark-ja.html2026-10-27https://daikikumakura.github.io/writing/shared/tumor-kinetics-landmark/figures/fig1-availability.pnghttps://daikikumakura.github.io/writing/shared/tumor-kinetics-landmark/figures/fig2-survival-discrimination.pnghttps://daikikumakura.github.io/writing/shared/tumor-kinetics-landmark/figures/fig3-next-measurement.pnghttps://daikikumakura.github.io/writing/tarlatamab-summary-pk.html2026-10-27https://daikikumakura.github.io/writing/shared/tarlatamab-summary-pk/figures/01-observed-fit.pnghttps://daikikumakura.github.io/writing/shared/tarlatamab-summary-pk/figures/02-time-course.pnghttps://daikikumakura.github.io/writing/shared/tarlatamab-summary-pk/figures/03-profiles.pnghttps://daikikumakura.github.io/writing/shared/tarlatamab-summary-pk/figures/04-maintenance.pnghttps://daikikumakura.github.io/writing/shared/tarlatamab-summary-pk/figures/05-equal-intensity.pnghttps://daikikumakura.github.io/writing/tarlatamab-summary-pk-en.html2026-10-27https://daikikumakura.github.io/writing/shared/tarlatamab-summary-pk/figures/01-observed-fit.pnghttps://daikikumakura.github.io/writing/shared/tarlatamab-summary-pk/figures/02-time-course.pnghttps://daikikumakura.github.io/writing/shared/tarlatamab-summary-pk/figures/03-profiles.pnghttps://daikikumakura.github.io/writing/shared/tarlatamab-summary-pk/figures/04-maintenance.pnghttps://daikikumakura.github.io/writing/shared/tarlatamab-summary-pk/figures/05-equal-intensity.pnghttps://daikikumakura.github.io/writing/ai-drug-discovery-bottlenecks.html2026-10-28https://daikikumakura.github.io/writing/ai-drug-discovery-bottlenecks-en.html2026-10-28https://daikikumakura.github.io/writing/tcell-engager-regimen-design.html2026-10-27https://daikikumakura.github.io/writing/shared/tcell-engager-regimen-design/figures/01-pk.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-regimen-design/figures/04-efficacy.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-regimen-design/figures/02-crs.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-regimen-design/figures/03-maintenance.pnghttps://daikikumakura.github.io/writing/tcell-engager-regimen-design-en.html2026-10-27https://daikikumakura.github.io/writing/shared/tcell-engager-regimen-design/figures/01-pk.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-regimen-design/figures/04-efficacy.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-regimen-design/figures/02-crs.pnghttps://daikikumakura.github.io/writing/shared/tcell-engager-regimen-design/figures/03-maintenance.pnghttps://daikikumakura.github.io/writing/warfarin-pkpd.html2026-10-27https://daikikumakura.github.io/writing/shared/warfarin-pkpd/figures/01-data-audit.pnghttps://daikikumakura.github.io/writing/shared/warfarin-pkpd/figures/02-model-diagnostics.pnghttps://daikikumakura.github.io/writing/shared/warfarin-pkpd/figures/03-held-out-predictions.pnghttps://daikikumakura.github.io/writing/shared/warfarin-pkpd/figures/04-paired-dose-scenarios.pnghttps://daikikumakura.github.io/writing/shared/warfarin-pkpd/figures/05-predictive-check.pnghttps://daikikumakura.github.io/writing/warfarin-pkpd-ja.html2026-10-27https://daikikumakura.github.io/writing/shared/warfarin-pkpd/figures/01-data-audit.pnghttps://daikikumakura.github.io/writing/shared/warfarin-pkpd/figures/02-model-diagnostics.pnghttps://daikikumakura.github.io/writing/shared/warfarin-pkpd/figures/03-held-out-predictions.pnghttps://daikikumakura.github.io/writing/shared/warfarin-pkpd/figures/04-paired-dose-scenarios.pnghttps://daikikumakura.github.io/writing/shared/warfarin-pkpd/figures/05-predictive-check.pnghttps://daikikumakura.github.io/writing/tumor-dynamics-survival.html2026-10-27https://daikikumakura.github.io/writing/shared/tumor-dynamics-survival/figures/early-sampling.pnghttps://daikikumakura.github.io/writing/shared/tumor-dynamics-survival/figures/heldout-performance.pnghttps://daikikumakura.github.io/writing/shared/tumor-dynamics-survival/figures/heldout-calibration.pnghttps://daikikumakura.github.io/writing/tumor-dynamics-survival-ja.html2026-10-27https://daikikumakura.github.io/writing/shared/tumor-dynamics-survival/figures/early-sampling.pnghttps://daikikumakura.github.io/writing/shared/tumor-dynamics-survival/figures/heldout-performance.pnghttps://daikikumakura.github.io/writing/shared/tumor-dynamics-survival/figures/heldout-calibration.pnghttps://daikikumakura.github.io/writing/mosunetuzumab-public-pk.html2026-10-28https://daikikumakura.github.io/writing/mosunetuzumab-public-pk-en.html2026-10-28https://daikikumakura.github.io/software/pkident.htmlhttps://daikikumakura.github.io/software/rsemflow.htmlhttps://daikikumakura.github.io/software/retiaudit.htmlhttps://daikikumakura.github.io/software/rlr-transform.htmlhttps://daikikumakura.github.io/software/crism.htmlhttps://daikikumakura.github.io/software/shotgunmetagenomics.htmlhttps://daikikumakura.github.io/software/dockerfiles.htmlhttps://daikikumakura.github.io/about/about-these-analyses.html2026-10-28https://daikikumakura.github.io/about/about-these-analyses-ja.html2026-10-28https://daikikumakura.github.io/tools/anti-pd1-exposure.html2026-10-22https://daikikumakura.github.io/tools/anti-pd1-exposure-ja.html2026-10-22https://daikikumakura.github.io/glossary/ctrough-trough-concentration.html2026-10-28https://daikikumakura.github.io/glossary/ctrough-trough-concentration-ja.html2026-10-28https://daikikumakura.github.io/glossary/dosing-interval-notation.html2026-10-28https://daikikumakura.github.io/glossary/dosing-interval-notation-ja.html2026-10-28https://daikikumakura.github.io/glossary/fixed-vs-weight-based-dosing.html2026-10-28https://daikikumakura.github.io/glossary/fixed-vs-weight-based-dosing-ja.html2026-10-28https://daikikumakura.github.io/glossary/landmark-analysis.html2026-10-22https://daikikumakura.github.io/glossary/landmark-analysis-ja.html2026-10-22https://daikikumakura.github.io/glossary/poppk-reimplementation.html2026-10-22https://daikikumakura.github.io/glossary/poppk-reimplementation-ja.html2026-10-22https://daikikumakura.github.io/glossary/practical-identifiability.html2026-10-22https://daikikumakura.github.io/glossary/practical-identifiability-ja.html2026-10-22https://daikikumakura.github.io/catalog/public-pk-models.html2026-10-22https://daikikumakura.github.io/catalog/public-pk-models-ja.html2026-10-22https://daikikumakura.github.io/glossary/qoi-cou.html2026-10-22https://daikikumakura.github.io/glossary/qoi-cou-ja.html2026-10-22https://daikikumakura.github.io/glossary/robust-mixture-prior.html2026-10-22https://daikikumakura.github.io/glossary/robust-mixture-prior-ja.html2026-10-22https://daikikumakura.github.io/glossary/step-up-dosing.html2026-10-22https://daikikumakura.github.io/glossary/step-up-dosing-ja.html2026-10-22https://daikikumakura.github.io/glossary/structural-identifiability.html2026-10-22https://daikikumakura.github.io/glossary/structural-identifiability-ja.html2026-10-22https://daikikumakura.github.io/reference.html2026-10-28